SAB Biotherapeutics (SABS) Free Cash Flow (2021 - 2026)
SAB Biotherapeutics (SABS) free cash flow from Mar 31, 2021 to Mar 31, 2026. The TTM SAB Biotherapeutics (SABS) free cash flow is -$53M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
SAB Biotherapeutics (SABS) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +68.49% |
| 3 Years TTM | +50.48% |
| 5 Years TTM | +171.55% |
| All Time TTM | +30.25% |
Annual Free Cash Flow change of SAB Biotherapeutics (SABS)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | -$15M | -66.64% |
| 2025 | -$46M | +32.00% |
| 2024 | -$35M | +36.77% |
| 2023 | -$25M | -1.21% |
| 2022 | -$26M | +256.96% |
| 2021 | -$7.18M | +163.00% |
| 2020 | -$2.73M | N/A |